HUP9802573A3 - Osteogenetic promoting pharmaceutical composition containing benzothian or benzothiepane derivatives and a biodegradable polimer - Google Patents
Osteogenetic promoting pharmaceutical composition containing benzothian or benzothiepane derivatives and a biodegradable polimerInfo
- Publication number
- HUP9802573A3 HUP9802573A3 HU9802573A HUP9802573A HUP9802573A3 HU P9802573 A3 HUP9802573 A3 HU P9802573A3 HU 9802573 A HU9802573 A HU 9802573A HU P9802573 A HUP9802573 A HU P9802573A HU P9802573 A3 HUP9802573 A3 HU P9802573A3
- Authority
- HU
- Hungary
- Prior art keywords
- benzothiepane
- benzothian
- polimer
- biodegradable
- derivatives
- Prior art date
Links
- KZPHSSFCYARZCD-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1-benzothiepine Chemical class S1CCCCC2=CC=CC=C21 KZPHSSFCYARZCD-UHFFFAOYSA-N 0.000 title 1
- WPWNEKFMGCWNPR-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromene Chemical compound C1=CC=C2CCCSC2=C1 WPWNEKFMGCWNPR-UHFFFAOYSA-N 0.000 title 1
- 230000002642 osteogeneic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13803695 | 1995-06-05 | ||
| JP1168696 | 1996-01-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9802573A2 HUP9802573A2 (hu) | 1999-09-28 |
| HUP9802573A3 true HUP9802573A3 (en) | 2000-04-28 |
Family
ID=26347166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9802573A HUP9802573A3 (en) | 1995-06-05 | 1996-06-04 | Osteogenetic promoting pharmaceutical composition containing benzothian or benzothiepane derivatives and a biodegradable polimer |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0831808A1 (zh) |
| KR (1) | KR19990022514A (zh) |
| AR (1) | AR003001A1 (zh) |
| AU (1) | AU717260B2 (zh) |
| CA (1) | CA2221784A1 (zh) |
| HU (1) | HUP9802573A3 (zh) |
| NO (1) | NO975636L (zh) |
| NZ (1) | NZ308658A (zh) |
| RU (1) | RU2188011C2 (zh) |
| TW (1) | TW420608B (zh) |
| WO (1) | WO1996039134A1 (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2264131A1 (en) * | 1996-08-26 | 1998-03-05 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition containing osteogenesis-promoting substance |
| WO1999065474A2 (en) * | 1998-06-15 | 1999-12-23 | Takeda Chemical Industries, Ltd. | Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds |
| EP1103552A4 (en) | 1998-08-07 | 2003-01-15 | Takeda Chemical Industries Ltd | BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE |
| EP1105140A2 (en) * | 1998-08-12 | 2001-06-13 | Takeda Chemical Industries, Ltd. | Benzothiepine compounds as enhancer of cell differentiation induction factor |
| WO2001089521A1 (fr) * | 2000-05-23 | 2001-11-29 | Takeda Chemical Industries, Ltd. | Compositions medicinales contenant des derives du tiophene |
| US6926903B2 (en) * | 2001-12-04 | 2005-08-09 | Inion Ltd. | Resorbable polymer composition, implant and method of making implant |
| WO2004077948A1 (ja) * | 2002-12-19 | 2004-09-16 | Nippon Soda Co., Ltd. | Oil/Water液中乾燥法による農薬マイクロカプセル製剤及びその製造方法 |
| JP5960593B2 (ja) | 2009-04-27 | 2016-08-02 | プレミア デンタル プロダクツ カンパニー | マイクロカプセル化組成物及び組織石灰化の方法 |
| US9814657B2 (en) | 2009-04-27 | 2017-11-14 | Premier Dental Products Company | Buffered microencapsulated compositions and methods |
| TWI458503B (zh) * | 2013-04-22 | 2014-11-01 | Medical & Pharm Ind Tech & Dev | 維生素ｋ微球、其製造方法、用途、及藥劑 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE203020T1 (de) * | 1990-05-30 | 2001-07-15 | Takeda Chemical Industries Ltd | Schwefel enthaltende heterocyclische verbindungen |
| US5716944A (en) * | 1994-07-04 | 1998-02-10 | Takeda Chemical Industries, Ltd. | Phosphonic acid compounds, their production and use |
| TW403757B (en) * | 1994-12-28 | 2000-09-01 | Takeda Chemical Industries Ltd | Optically active benzothiepin derivative, its preparation and use |
-
1996
- 1996-06-04 CA CA002221784A patent/CA2221784A1/en not_active Abandoned
- 1996-06-04 WO PCT/JP1996/001506 patent/WO1996039134A1/en not_active Application Discontinuation
- 1996-06-04 EP EP96920042A patent/EP0831808A1/en not_active Withdrawn
- 1996-06-04 NZ NZ308658A patent/NZ308658A/en unknown
- 1996-06-04 AU AU58457/96A patent/AU717260B2/en not_active Ceased
- 1996-06-04 AR ARP960102893A patent/AR003001A1/es unknown
- 1996-06-04 KR KR1019970708995A patent/KR19990022514A/ko not_active Application Discontinuation
- 1996-06-04 RU RU98100111/14A patent/RU2188011C2/ru not_active IP Right Cessation
- 1996-06-04 HU HU9802573A patent/HUP9802573A3/hu unknown
- 1996-06-05 TW TW085106698A patent/TW420608B/zh not_active IP Right Cessation
-
1997
- 1997-12-04 NO NO975636A patent/NO975636L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU5845796A (en) | 1996-12-24 |
| AR003001A1 (es) | 1998-05-27 |
| NZ308658A (en) | 1999-10-28 |
| KR19990022514A (ko) | 1999-03-25 |
| HUP9802573A2 (hu) | 1999-09-28 |
| WO1996039134A1 (en) | 1996-12-12 |
| EP0831808A1 (en) | 1998-04-01 |
| RU2188011C2 (ru) | 2002-08-27 |
| TW420608B (en) | 2001-02-01 |
| AU717260B2 (en) | 2000-03-23 |
| CA2221784A1 (en) | 1996-12-12 |
| NO975636L (no) | 1998-01-28 |
| NO975636D0 (no) | 1997-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL116851A (en) | 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them | |
| IL116917A (en) | Piperidine derivatives and pharmaceutical compositions containing them | |
| HUP0002209A3 (en) | 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them | |
| IL111221A0 (en) | N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them | |
| HUP0000474A3 (en) | Arylethenesulfonamide derivatives and drug composition containing the same | |
| HUP9900424A2 (hu) | Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0003362A2 (en) | Piperidine derivatives and pharmaceutical compositions containing them | |
| HUP0001494A3 (en) | 3-phenoxy-, 3-dibenzo[a,d]cycloheptenyloxy-, 3-dibenz[b,f][1,4]oxazepinyloxy-1-amino-2-propanol derivatives and pharmaceutical compositions containing them | |
| HUP9901344A3 (en) | Radicicol derivatives and pharmaceutical compositions thereof | |
| HUP0002510A3 (en) | Tetrazole derivatives and pharmaceutical compositions containing them | |
| HUP9802290A3 (en) | Pyrrole derivatives and pharmaceutical compositions containing them | |
| AU5856898A (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
| IL118221A0 (en) | Substituted cephalosporins and pharmaceutical compositions containing them | |
| ZA967800B (en) | Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them | |
| HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
| HUP9602196A3 (en) | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof | |
| IL119215A0 (en) | Cephalosporin derivatives their manufacture and pharmaceutical compositions containing them | |
| HUP0002331A3 (en) | 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof | |
| HUP9802573A3 (en) | Osteogenetic promoting pharmaceutical composition containing benzothian or benzothiepane derivatives and a biodegradable polimer | |
| IL115113A0 (en) | Pyridinium derivatives and pharmaceutical compositions containing them | |
| IL120722A0 (en) | Carbohydrate derivatives and pharmaceutical compositions containing them | |
| HUP0102086A2 (hu) | 8-Azabiciklo[3.2.1]oktán-3-metánamin-származékok és az azokat tartalmazó gyógyászati készítmények | |
| HUP9802291A3 (en) | Penicillaminamide derivatives and pharmaceutical compositions containing them | |
| IL116893A (en) | Piperazine derivatives and pharmaceutical compositions containing them | |
| ZA982457B (en) | Pharmaceutical compositions containing propanaminde derivatives and cyclodextrin |